文献速递心脏核医学

运动与药物负荷心肌灌注显像患者的死亡风险:基于倾向性匹配的比较

Mortality risk among patients undergoing exercise versus pharmacologic myocardial perfusion imaging: A propensity-based comparison.
PubMed 文献 · J Nucl Cardiol · 2020-10-12

该研究对39179例接受负荷/静息SPECT心肌灌注显像的患者随访13.3±5.0年,采用倾向性匹配比较运动与药物负荷患者的全因死亡率。结果显示,在每一缺血水平上,药物负荷患者的风险调整后全因死亡风险均显著高于运动负荷患者,即使在无缺血患者中亦如此。

要点

  • 药物负荷患者在各缺血水平全因死亡风险均高于运动负荷患者。
  • 无缺血患者中药物负荷全因死亡风险增加3.8倍(95%CI 3.5-4.1)。
  • 倾向性匹配队列(各10113例)及排除非心脏共病队列结果一致。

核心结论

  • 需要药物负荷试验的患者在每一心肌缺血水平上均表现出显著增高的临床风险,即使无心肌缺血时亦然。

研究设计与样本

  • 回顾性队列研究,纳入39179例接受负荷/静息SPECT心肌灌注显像的患者,随访13.3±5.0年,采用倾向性匹配创建风险特征相似的药物负荷与运动负荷组。

主要发现

  • 与运动负荷患者相比,药物负荷患者风险调整后全因死亡风险在无缺血患者中增加3.8倍(95%CI 3.5-4.1),轻度缺血患者中增加2.5倍(95%CI 2.0-3.2),中/重度缺血患者中增加2.6倍(95%CI 2.1-3.3)。
  • 在10113例运动负荷与10113例药物负荷的倾向性匹配队列中观察到相似结果。
  • 在额外排除非心脏共病患者的队列中亦观察到相似结果。

临床怎么用

  • 临床报告应传达药物负荷试验相关的增高风险。
  • 需研究药物负荷试验相关风险增高的病理生理驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increased risk associated with pharmacologic versus exercise testing is obscured by the higher prevalence of clinical risk factors among pharmacologic patients. Thus, we assessed comparative mortality in a large risk factor-matched group of exercise versus pharmacologic patients undergoing stress/rest SPECT myocardial perfusion imaging (MPI). METHODS: 39,179 patients undergoing stress/rest SPECT-MPI were followed for 13.3 ± 5.0 years for all-cause mortality (ACM). We applied propensity-matching to create pharmacologic and exercise groups with similar risk profiles. RESULTS: In comparison to exercise patients, pharmacologic patients had an increased risk-adjusted hazard ratio for ACM for each level of ischemia: increased by 3.8-fold (95%CI 3.5-4.1) among nonischemic patients, 2.5-fold (95%CI 2.0-3.2) among mildly ischemic patients, and 2.6-fold (95%CI 2.1-3.3) among moderate/severe ischemic patients. Similar findings were observed among a propensity-matched cohort of 10,113 exercise and 10,113 pharmacologic patients as well as in an additional cohort that also excluded patients with noncardiac co-morbidities. CONCLUSIONS: Patients requiring pharmacologic stress testing manifest substantially heightened clinical risk at each level of myocardial ischemia and even when myocardial ischemia is absent. These findings suggest the need to study the pathophysiological drivers of increased risk in association with pharmacologic testing and to convey this risk in clinical reports.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Rozanski A, Gransar H, Hayes SW, et al. Mortality risk among patients undergoing exercise versus pharmacologic myocardial perfusion imaging: A propensity-based comparison. J Nucl Cardiol. 2020. PMID: 33047282. doi:10.1007/s12350-020-02294-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。